Pfizer-BioNTech COVID-19 Vaccine

Global Information About Pfizer‑BioNTech COVID‑19 Vaccine (also known as BNT162b2)

The approval status of the Pfizer‑BioNTech COVID‑19 Vaccine varies worldwide. In countries where the vaccine has not been approved by the relevant regulatory authority, it is an investigational drug, and its safety and efficacy have not been established.

As country information may vary, please choose the country below in which you are a licensed healthcare professional for more information on the Pfizer‑BioNTech COVID‑19 Vaccine.

Information about the Pfizer‑BioNTech COVID‑19 Vaccine is only available for certain countries. This site will be updated as more information becomes available.